The insurance company is offering the guidance in response to continued popularity of the drugs which are commonly used for weight-loss management.
Stock.adobe.com
Over the past two years, GLP-1s have become one of the most popular medications in the United States. Due to medications’ impact on appetite and eating habits, they’ve become very popular weight loss drugs for many people who struggling with obesity. As such, demand for the drugs has increased, which has caused insurance companies to develop strategies on how to help their customers obtain these medications while also ensure that they are doing so in a healthy way.
Personify Health, a healthcare insurance provider, recently shared best practices for GLP-1s for employers who utilize Personify’s services.1 These practices are based on three recommendations:
In a press release, Presonify Health’s chief medical officer Jeffrey Jacques, MD, said, “The dozens of inquiries I've fielded in the past several months make it clear that management of GLP-1s and their associated cost burdens are a top priority for most employers today. Whether they select our Transform program, or a dedicated solution from our partner ecosystem, clients using our platform will experience a personalized program, combining 1:1 support and AI-driven technology that engages and empowers their populations. GLP-1s aren't going away–the list of health conditions they may be able to address is only expanding, so it's critical that employers carve a path forward. Our approach will remain relevant and effective, now and in the future."
Personify Health is a relatively new company, which was birthed last November when Virgin Pulse and Healthcomp merged. In February of this year, the two companies unveiled the new company brand.2
In a press release issued at the time, Personify Health’s chief marketing officer Erica Sniad Morgenstern said, “Our company's strengths around personalization, human centricity, and high-touch partnerships provide compelling and differentiated opportunities for the new brand. Personify Health emphasizes our commitment to creating health experiences that put people at the center of every interaction. With the global scale of our platform, we help millions of people feel connected and supported when navigating everything from daily wellbeing routines to health complexities."
In the same press release, Personify Health’s CEO Chris Michalak said, “Personify Health is focused on helping real people with real needs by enabling our clients to make better decisions about the health benefits they provide–and then making them easy for people to use. We are bringing more humanity to a category that is, unfortunately, all too often lacking it. Our personalized health platform delivers modern, engaging experiences that motivate people to manage, improve, and sustain their health–leading to better outcomes for themselves and their companies."
"We are on a mission to engage and empower people to lead healthier lives," Michalak added. "The introduction of our new company brand is the first step to achieving this purpose-driven goal that motivates our people and clients every day."
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.